x

Posted 30 June, 2023

INTENSITY THERAPEUTICS, INC. IPO completed

IPO completed detected for ticker Nasdaq:INTS in a 424B4 filed on 30 June, 2023.


  This is our initial public offering.  

Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of INTENSITY THERAPEUTICS, INC.
None • None
Intensity Therapeutics, Inc. engages in the operation a biotechnology company which develops novel immune-based therapeutic products for cancer treatment. Its product INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine. The company was founded by Lewis H. Bender in 2012 and is headquartered in Westport, CT.
Market Cap
$62.9M
View Company Details